期刊
JOURNAL OF NEUROSCIENCE
卷 36, 期 5, 页码 1577-1589出版社
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2010-15.2016
关键词
compensatory mechanisms; dopamine; MPTP; Parkinson's disease; PET imaging; serotonin
资金
- French National Agency of Research [ANR-09-MNPS-018]
It is now widely accepted that compensatory mechanisms are involved during the early phase of Parkinson's disease (PD) to delay the expression of motor symptoms. However, the neurochemical mechanisms underlying this presymptomatic period are still unclear. Here, we measured in vivo longitudinal changes of both the dopaminergic and serotonergic systems in seven asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated monkeys (when motor symptoms are less apparent) using PET. We used the progressively MPTP-intoxicated monkey model that expresses recovery from motor symptoms to study the changes in dopamine synthesis ([F-18] DOPA), dopamine D-2/D-3 receptors ([C-11] raclopride), and serotonin transporter C-11-N, N-dimethyl-2-(-2-amino-4-cyanophenylthio) benzylamine ([C-11] DASB) and serotonin 1A receptor ([F-18] MPPF) levels between four different states (baseline, early symptomatic, full symptomatic and recovered). During the early symptomatic state, we observed increases of [F-18] DOPA uptake in the anterior putamen, [C-11] raclopride binding in the posterior striatum, and 2'-methoxyphenyl-(N-2'-pyridinyl)-p-[F-18] fluoro-benzamidoethylpiperazine [F-18 ] MPPF uptake in the orbitofrontal cortex and dorsal ACC. After recovery from motor symptoms, the results mainly showed decreased [C-11] raclopride binding in the anterior striatum and limbic ACC. In addition, our findings supported the importance of pallidal dopaminergic neurotransmission in both the early compensatory mechanisms and the functional recovery mechanisms, with reduced aromatic L-amino acid decarboxylase (AAAD) activity closely related to the appearance or perseveration of motor symptoms. In parallel, this study provides preliminary evidence of the role of the serotonergic system in compensatory mechanisms. Nonetheless, future studies are needed to determine whether there are changes in SERT availability in the early symptomatic state and if [F-18] MPPF PET imaging might be a promising biomarker of early degenerative changes in PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据